Standard High-Dose Alpha Interferon Versus Intermittent High-Dose Alpha Interferon
Status:
Unknown status
Trial end date:
2005-09-01
Target enrollment:
Participant gender:
Summary
The study protocol is being conducted to compare intermittent high-dose i.v. administation of
interferon alpha-2b with the standard high-dose treatment by Kirkwood with distant metastasis
free survival (DMFI) as a primary endpoint.